Investigation of the Effectiveness of Exercise and Anti-Fibrotic Approaches in Frozen Shoulder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIstanbul University

About this trial

The purpose of this clinical study is to investigate the efficacy of losartan as an antifibrotic approach in addition to a physiotherapy program in patients diagnosed with frozen shoulder. The effects of losartan use on pain intensity, shoulder joint range of motion, functional status, and pain catastrophizing level will be evaluated and compared with the outcomes of patients participating in a physiotherapy program alone.

The key questions this study aims to answer are:

* Is there a difference in shoulder functionality between frozen shoulder patients using losartan in addition to a physiotherapy program and those participating in a physiotherapy program alone? * Is there a difference in pain intensity, shoulder joint range of motion, and pain catastrophizing level between frozen shoulder patients using losartan in addition to a physiotherapy program and those participating in a physiotherapy program alone? A total of 33 patients will be enrolled in the study. Participants will be randomly assigned to one of two groups: the physiotherapy group (PT) and the physiotherapy + losartan group (PT+L). Both groups will receive the same physiotherapy program comprising range of motion exercises, stretching exercises, strengthening exercises, and mobilization techniques. Patients in the PT+L group will additionally receive 12.5 mg of oral losartan once daily for four weeks. Clinical assessments will be conducted at baseline, at week 4, and at week 8.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 18 years or older diagnosed with frozen shoulder (adhesive capsulitis)

Having less than 50% of range of motion (ROM) in at least one of the following shoulder movements compared to the unaffected side: external rotation, abduction, flexion, or internal rotation

Having more than 25% loss of ROM in at least two movement planes compared to the unaffected shoulder

Patients in stage II or III of frozen shoulder

Disqualifiers

Women who are pregnant, breastfeeding, or planning pregnancy during the study

Patients in stage I of frozen shoulder

Patients diagnosed with inflammatory or other types of arthritis due to autoimmune diseases affecting the shoulder

Patients with rotator cuff pathology and/or glenohumeral arthritis

Trial design

Design model

Parallel

Treatments tested in this trial

  • Patient Education

    Other intervention

    During the first session, participants will receive information about the stages and prognosis of frozen shoulder and recommended sleeping positions for patients who have difficulty sleeping at night due to pain.

  • Shoulder Exercise Therapy

    Other intervention

    Participants in both groups will be enrolled in a structured exercise program consisting of exercises recommended in the literature. This program includes range of motion, stretching, and strengthening exercises. The exercises will be performed under the supervision of a physiotherapist, twice a week for four weeks, totaling eight sessions.

  • Losartan

    Drug

    Participants will receive 12.5 mg of oral losartan once daily for four weeks.

  • Joint Mobilization Techniques

    Other intervention

    Glenohumeral joint distraction and anterior, posterior, and inferior glides will be applied. Each technique will be performed for 2 minutes, with 3 repetitions. The intensity of the mobilization techniques will be adjusted according to each patient's pain and tolerance levels.

  • Cold Application

    Other intervention

    A cold pack will be applied for 15 minutes after each exercise session.

Treatment groups

33 Participants
are divided into 2 treatment groups
Group A: Physiotherapy Group (FT)Active comparator 4 interventions
Group B: Physiotherapy + Losartan Group (FT+L)Experimental treatment 5 interventions

Trial outcomes

Primary outcomes

1

Quick Disabilities of the Arm, Shoulder and Hand Questionnaire (QuickDASH)

The Q-DASH is a questionnaire used to assess upper extremity function and symptoms. It consists of 11 items, each scored from 1 to 5. The total score ranges from 0 to 100, with higher scores indicating greater functional limitation.

Time frame
At baseline, at week 4, and at week 8

Secondary outcomes

1

Numeric Pain Rating Scale (NPRS)

Patients' pain at rest, during activity, and at night will be assessed using the NPRS. The NPRS is scored from 0 to 10, with 0 indicating "no pain" and 10 indicating "worst imaginable pain."

Time frame
At baseline, at week 4, and at week 8
2

American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES)

The ASES is a questionnaire used to assess patients' shoulder function and pain levels. The scale consists of 10 items. The total score ranges from 0 to 100, with higher scores indicating better functional ability.

Time frame
At baseline, at week 4, and at week 8
3

Pain Catastrophizing Scale (PCS)

Pain Catastrophizing Scale (PCS) is used to assess individuals' levels of pain catastrophizing. The scale consists of 13 items, each scored from 1 to 4. Total score ranges from 0 to 52, with higher scores indicating greater levels of pain catastrophizing.

Time frame
At baseline, at week 4, and at week 8
4

Shoulder Range of Motion

Shoulder range of motion will be measured in degrees using a universal goniometer. Measurements will include flexion, abduction, external rotation, and internal rotation.

Time frame
At baseline, at week 4, and at week 8

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Istanbul University

Lead sponsor

Istanbul University - Cerrahpasa

Sponsor institution